Approving the Vagus-Nerve Stimulator for Depression
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
The vagus-nerve stimulator (VNS), a device that is implanted by a neurosurgeon and sends intermittent electrical pulses to the brain, has been marketed in the United States since 1997 as an adjunctive therapy for the control of epilepsy. Debate is ongoing, however, over the use of the device in patients with refractory depression. Though the key clinical questions (Does it work? Is it safe?) seem straightforward, answering them is proving rather complicated. The Food and Drug Administration (FDA) approved the use of the VNS for depression in 2005, but in February 2007, the Centers for Medicare and Medicaid Services issued . . .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schneider, L. S., Dagerman, K. S., & Insel, P. (2005) · JAMA · doi:10.1001/jama.294.15.1934 · Cited by 1,671
beta Blockade after myocardial infarction: systematic review and meta regression analysis
Freemantle, N., Cleland, J., Young, P., Mason, J., & Harrison, J. (1999) · BMJ · doi:10.1136/bmj.318.7200.1730 · Cited by 1,509
Rothman, R. B., Baumann, M. H., Savage, J. E., Rauser, L., McBride, A., Hufeisen, S. J., & Roth, B. L. (2000) · Circulation · doi:10.1161/01.cir.102.23.2836 · Cited by 722
Drugs and Valvular Heart Disease
Roth, B. L. (2007) · New England Journal of Medicine · doi:10.1056/nejmp068265 · Cited by 479
Meta‐analysis: proton‐pump inhibition in high‐risk patients with acute peptic ulcer bleeding
Bardou, M., Toubouti, Y., Benhaberou‐Brun, D., Rahme, E., & Barkun, A. N. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02391.x · Cited by 132
Cited by
Chronic vagus nerve stimulation: A new and promising therapeutic approach for chronic heart failure
De Ferrari, G. M., Crijns, H. J. G. M., Borggrefe, M., Milasinovic, G., Smid, J., Zabel, M., Gavazzi, A., Sanzo, A., Dennert, R., Kuschyk, J., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehq391 · Cited by 523
Long Term Vagal Stimulation in Patients with Advanced Heart Failure First Experience in Man
Schwartz, P. J., De Ferrari, G. M., Sanzo, A., Landolina, M., Rordorf, R., Raineri, C., Campana, C., Revera, M., Ajmone-Marsan, N., Tavazzi, L., et al. (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2008.07.016 · Cited by 302
Vagus nerve stimulation for depression: efficacy and safety in a European study
Schlaepfer, T. E., Frick, C., Zobel, A., Maier, W., Heuser, I., Bajbouj, M., O'Keane, V., Corcoran, C., Adolfsson, R., Trimble, M., et al. (2008) · Psychological Medicine · doi:10.1017/s0033291707001924 · Cited by 205
“It has been argued that a controlled design would be unethical, because eligible patients would be too depressed to be taken off their medications and given only sham stimulation (Shuchman, 2007).”
BackgroundVagus nerve stimulation: From pre-clinical to clinical application: Challenges and future directions
De Ferrari, G. M., & Schwartz, P. J. (2011) · Heart Failure Reviews · doi:10.1007/s10741-010-9216-0 · Cited by 169
Rizvi, S. J., Donovan, M., Giacobbe, P., Placenza, F., Rotzinger, S., & Kennedy, S. H. (2011) · International Review of Psychiatry · doi:10.3109/09540261.2011.630993 · Cited by 42
“This was a controversial decision, due to the lack of evidence of acute effi - cacy in the randomized sham controlled trial (Shuchman, 2007).”
Background
Metadata
- Authors
- Shuchman, M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-04-19
- Volume
- 356
- Issue
- 16
- Pages
- 1604-1607
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2165089352
- Cited by
- 60
- References
- 5
- FWCI
- 3.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Approving the Vagus-Nerve Stimulator for Depression. https://app.cochat.ai/papers/10.1056/nejmp078035
- The paper
- Shuchman, M. (2007). Approving the Vagus-Nerve Stimulator for Depression. New England Journal of Medicine. https://doi.org/10.1056/nejmp078035
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.